Fig. 4. Cumulative incidence curves for a ≥ 40% decline of eGFR from the baseline eGFR at the time of initiation of systemic therapy.

The curves are stratified by people who (a) did or did not have nephrectomy prior to systemic therapy and (b) by those who did or did not have prevalent diabetes.